scholarly journals ATIM-13. PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T CELLS TARGETING IL13Rα2 FOR THE TREATMENT OF GLIOBLASTOMA

2016 ◽  
Vol 18 (suppl_6) ◽  
pp. vi20-vi20 ◽  
Author(s):  
Christine Brown ◽  
Darya Alizadeh ◽  
Renate Starr ◽  
Lihong Weng ◽  
Jamie Wagner ◽  
...  
Keyword(s):  
T Cells ◽  
Phase I ◽  
Chimeric Antigen Receptor ◽  
Phase I Study ◽  
Antigen Receptor ◽  
Engineered T Cells

scholarly journals 247. Phase I Study of Second Generation Chimeric Antigen Receptor-Engineered T Cells Targeting IL13Rα2 for the Treatment of Glioblastoma

2016 ◽  
Vol 24 ◽  
pp. S97 ◽  
Author(s):  
Christine E. Brown ◽  
Renate Starr ◽  
Lihong Weng ◽  
Darya Alizadeh ◽  
Jamie R. Wagner ◽  
...  
Keyword(s):  
T Cells ◽  
Phase I ◽  
Chimeric Antigen Receptor ◽  
Phase I Study ◽  
Second Generation ◽  
Antigen Receptor ◽  
Engineered T Cells

Abstract LB-083: Phase I study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII+ glioblastoma

2016 ◽  
Author(s):  
Donald M. O’Rourke ◽  
MacLean P. Nasrallah ◽  
Jennifer Morrissette ◽  
Jan J. Melenhorst ◽  
Simon F. Lacey ◽  
...  
Keyword(s):  
T Cells ◽  
Phase I ◽  
Chimeric Antigen Receptor ◽  
Phase I Study ◽  
Antigen Receptor

scholarly journals Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

2019 ◽  
Vol 27 (11) ◽  
pp. 1919-1929 ◽  
Author(s):  
Andrew R. Haas ◽  
Janos L. Tanyi ◽  
Mark H. O’Hara ◽  
Whitney L. Gladney ◽  
Simon F. Lacey ◽  
...  
Keyword(s):  
T Cells ◽  
Phase I ◽  
Chimeric Antigen Receptor ◽  
Phase I Study ◽  
Antigen Receptor
Sign in / Sign up

Export Citation Format

Share Document